Blood pressure control

By  

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol. 21, Iss. 2, 2015-04 ,pp. : 313-319

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes

By Neutel Joel M.   Kereiakes Dean J.   Waverczak William F.   Stoakes Kathy A.   Xu Jianbo   Shojaee Ali  

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 721-728

Informa Healthcare

Access to resources Recommend Favorite

Assessing blood pressure control in patients treated for hypertension: comparing different measurements and targets

By Manning Gillian   Brooks Andrew   Slinn Barbara   Millar-Craig Michael W   Donnelly Richard  

British Journal of General Practice, Vol. 56, Iss. 526, 2006-05 ,pp. : 375-377

Royal College of General Practitioners

Access to resources Recommend Favorite

Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis

By Palmer Andrew   Valentine William   Ray Joshua   Roze Stephane   Muszbek Noemi  

The European Journal of Health Economics, Vol. 8, Iss. 2, 2007-06 ,pp. : 161-168

Springer Publishing Company

Access to resources Recommend Favorite

Effect on blood pressure control of switching from valsartan monotherapy to losartan/hydrochlorothiazide in Asian patients with hypertension: results of a multicentre open-label trial

By Watanabe Luis A.   Wei Meng   Sun Ningling   Kim Dongsoo   Chiang Chern-En   Ke Yuannan   Tseng Chuen-Den   Coloma Ricardo   Vala M.   Massaad R.   Feig P.   Guptha S.  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 1955-1964

Informa Healthcare

Access to resources Recommend Favorite